- Trials with a EudraCT protocol (167)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
167 result(s) found for: Circulating Tumor Dna.
Displaying page 1 of 9.
EudraCT Number: 2011-002544-27 | Sponsor Protocol Number: CSTI571BDE78T | Start Date*: 2011-10-18 |
Sponsor Name:Technische Universitaet Muenchen Fakultaet fuer Medizin | ||
Full Title: Prospective, explorative trial for the detection of circulating cell-free tumor DNA in the plasma of patients with gastrointestinal stromal tumors (GIST) harboring activating mutations of CKIT or P... | ||
Medical condition: Patients with gastrointestinal stromal tumor (GIST) harboring activating mutations of CKIT or PDGFRA pre/post surgery or pre/under treatment with a Tyrokinase Inhibitors or progressive disease irre... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004418-17 | Sponsor Protocol Number: I-BCT-1 | Start Date*: 2014-05-07 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological rationale for the optimal selection of treatment regimens. | ||
Medical condition: breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004262-34 | Sponsor Protocol Number: GRASPANC2013-03 | Start Date*: 2014-02-24 | |||||||||||
Sponsor Name:ERYTECH Pharma | |||||||||||||
Full Title: Phase II, randomized, controlled, clinical trial exploring efficacy and safety of ERY001 (L-asparaginase encapsulated in Red Blood Cells) in association with gemcitabine or FOLFOX4 in second-line t... | |||||||||||||
Medical condition: Pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000682-36 | Sponsor Protocol Number: NL65109.091.18 | Start Date*: 2018-07-05 |
Sponsor Name:Radboud university medical center | ||
Full Title: The efficacy of cabozantinib in advanced salivary gland cancer patients, a phase II clinical trial | ||
Medical condition: Salivary gland cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-004760-21 | Sponsor Protocol Number: BIO-TAILOR | Start Date*: 2020-10-07 | |||||||||||
Sponsor Name:FONDAZIONE MELANOMA ONLUS | |||||||||||||
Full Title: Dabrafenib and trametinib in circulating free DNA BRAFV600 mutated metastatic melanoma patients: a prospective phase II, open label, multicentre study – (Bioliquid TAILOR study – BIO-TAILOR) | |||||||||||||
Medical condition: Metastatic melanoma patients with tissue BRAFWT signature and a molecular shift to circulating free DNA BRAF mutated positive melanomas upon progression to an anti PD-1 therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004860-12 | Sponsor Protocol Number: ERCAVATAR2015 | Start Date*: 2016-02-24 | |||||||||||
Sponsor Name:Centro Nacional Investigaciones Oncológicas (CNIO) | |||||||||||||
Full Title: Integrated Genomics and Avatar Mouse Models for Personalized Treatment of Pancreatic Cancer | |||||||||||||
Medical condition: Metastatic pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001587-38 | Sponsor Protocol Number: OPTIPRIME | Start Date*: 2019-08-05 |
Sponsor Name:Fédération Francophone de Cancérologie Digestive | ||
Full Title: A phase II study evaluating FOLFOX + panitumumab according to a "stop and go" strategy with a reintroduction loop after progression on fluoropyrimidine as maintenance treatment, as the first line i... | ||
Medical condition: metastatic colorectal adenocarcinoma without a RAS mutation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005838-22 | Sponsor Protocol Number: CLIO | Start Date*: 2016-07-22 |
Sponsor Name:UZLeuven | ||
Full Title: Circulating tumor DNA guiding (Olaparib) Lynparza® treatment in Ovarian Cancer (CLIO). Establishing the value of a ctDNA-based HRD assay for predicting olaparib response in women with relapsed ovar... | ||
Medical condition: platinum-sensitive and platinum-resistant relapsed ovarian cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012738-65 | Sponsor Protocol Number: CTC PLATINUM | Start Date*: 2008-10-15 | |||||||||||
Sponsor Name:AZIENDA USL 4 PRATO | |||||||||||||
Full Title: CLINICAL ACTIVITY OF DNA DAMAGING AND NON-DAMAGING CHEMIOTHERAPY REGIMENS IN ADVANCED BREAST CANCER PATIENTS WITH DIFFERENT BIOLOGICAL SUB-TYPES DEFINED BY BIOMARKERS EVALUATION ON CIRCULATING TUMO... | |||||||||||||
Medical condition: METASTATIC BREAST CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000494-20 | Sponsor Protocol Number: ABC-SE | Start Date*: 2016-07-03 | |||||||||||
Sponsor Name:Skåne University Hospital, Department of Oncology | |||||||||||||
Full Title: A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Based Treatment with Focus on Mechanisms of Resistance to Endocrine Based Treatment (fulvestrant/aroma... | |||||||||||||
Medical condition: Estrogen receptor positive metastatic or locally advanced inoperable breast cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000501-13 | Sponsor Protocol Number: 1317-STBSG | Start Date*: 2017-02-10 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer (EORTC) | |||||||||||||
Full Title: Phase II study of cabozantinib in patients with metastatic gastrointestinal stromal tumor (GIST) who progressed during neoadjuvant, adjuvant or palliative therapy with imatinib and sunitinib | |||||||||||||
Medical condition: metastatic gastrointestinal stromal tumor (GIST) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) HU (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000551-41 | Sponsor Protocol Number: IMPACT_Breast_6.3 | Start Date*: 2014-03-18 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Towards patient tailored cancer treatment supported by molecular imaging IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic Breast Cancer | ||
Medical condition: Metastatic Breast Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003103-56 | Sponsor Protocol Number: ENTO-R-CHOP | Start Date*: 2017-05-09 | |||||||||||
Sponsor Name:LYSARC | |||||||||||||
Full Title: A phase Ib - II study of Entospletinib (ENTO) in newly diagnosed Diffuse Large B Cell Lymphoma (DLBCL) patients with aaIPI ≥1 treated by R-CHOP | |||||||||||||
Medical condition: Diffuse Large B Cell Lymphoma (DLBCL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002285-23 | Sponsor Protocol Number: POETIG | Start Date*: 2017-01-18 | |||||||||||
Sponsor Name:Universitaetsklinikum Essen | |||||||||||||
Full Title: Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure or intolerance of prior therapy with imatinib (POETIG trial – POna... | |||||||||||||
Medical condition: gastrointestinal stromal tumor (GIST) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003732-20 | Sponsor Protocol Number: GECP16/03 | Start Date*: 2017-01-24 |
Sponsor Name:Grupo Español de Cáncer de Pulmón | ||
Full Title: NEO -ADJUVANT CHEMO/IMMUNOTHERAPY FOR THE TREATMENT OF RESECTABLE STAGE IIIA NON SMALL CELL LUNG CANCER (NSCLC): A PHASE II MULTICENTER EXPLORATORY STUD | ||
Medical condition: Non small cell lung cáncer limited stage IIIA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004231-12 | Sponsor Protocol Number: NL20151001 | Start Date*: 2016-08-08 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Early identification of patients who benefit from palbociclib in addition to letrozole | ||
Medical condition: estrogen receptor positive metastatic breast cancer patients eligible for palbociclib plus letrozole treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004126-13 | Sponsor Protocol Number: CaPture | Start Date*: 2020-10-06 |
Sponsor Name:University Leipzig | ||
Full Title: Cabozantinib treatment in a phase II study for patients with hepatocellular carcinoma (HCC) refractory to PD-1 or PD-L1 inhibitors | ||
Medical condition: Hepatocellular carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004927-27 | Sponsor Protocol Number: RELAIS | Start Date*: 2014-12-17 |
Sponsor Name:Med. Univ. Wien, Innere Med. I | ||
Full Title: REgorafenib’s Liquid BiopsY (RELY): A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer. a non-profit investigator-init... | ||
Medical condition: non-resectable pretreated colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004429-15 | Sponsor Protocol Number: GEM-1402 | Start Date*: 2016-02-16 | |||||||||||
Sponsor Name:GRUPO ESPAÑOL MULTICISPLINAR DE MELANOMA | |||||||||||||
Full Title: Phase II multicente, non randomized, open label trial of nivolumab in combination with ipilimumab in subjects with previously untreated metastatic uveal melanoma. | |||||||||||||
Medical condition: Metastatic uveal melanoma non suitable for radical resection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005086-40 | Sponsor Protocol Number: J1214 | Start Date*: 2014-05-21 | |||||||||||
Sponsor Name:Sidney kimmel Comprehensive Cancer Center at Johns Hopkins | |||||||||||||
Full Title: A multi-institutional open label, trial evaluating the efficacy of Gemcitabine and Docetaxel in patients with relapsed or refractory metastatic colorectal adenocarcinoma with methylated CHFR and/or... | |||||||||||||
Medical condition: relapsed or refractory metastatic colorectal adenocarcinoma with methylation of CHFR and/or microsatellite instability | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.